Summary
Global Markets Direct’s, ‘Sun Pharma Advanced Research Company Ltd. - Product Pipeline Review - 2016’, provides an overview of the Sun Pharma Advanced Research Company Ltd.’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Sun Pharma Advanced Research Company Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Sun Pharma Advanced Research Company Ltd.
- The report provides overview of Sun Pharma Advanced Research Company Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Sun Pharma Advanced Research Company Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Sun Pharma Advanced Research Company Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Sun Pharma Advanced Research Company Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Sun Pharma Advanced Research Company Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Sun Pharma Advanced Research Company Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
'
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Sun Pharma Advanced Research Company Ltd. Snapshot 6
Sun Pharma Advanced Research Company Ltd. Overview 6
Key Information 6
Key Facts 6
Sun Pharma Advanced Research Company Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
Sun Pharma Advanced Research Company Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Combination Treatment Modalities 12
Pipeline Products - Partnered Products 13
Partnered Products/Combination Treatment Modalities 14
Sun Pharma Advanced Research Company Ltd. - Pipeline Products Glance 15
Sun Pharma Advanced Research Company Ltd. - Late Stage Pipeline Products 15
Pre-Registration Products/Combination Treatment Modalities 15
Filing rejected/Withdrawn Products/Combination Treatment Modalities 16
Phase III Products/Combination Treatment Modalities 17
Sun Pharma Advanced Research Company Ltd. - Clinical Stage Pipeline Products 18
Phase II Products/Combination Treatment Modalities 18
Phase I Products/Combination Treatment Modalities 19
Sun Pharma Advanced Research Company Ltd. - Early Stage Pipeline Products 20
Preclinical Products/Combination Treatment Modalities 20
Discovery Products/Combination Treatment Modalities 21
Sun Pharma Advanced Research Company Ltd. - Drug Profiles 22
latanoprost 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
baclofen ER 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
tildrakizumab 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
paclitaxel albumin free 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
tizanidine hydrochloride ER 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SUNK-706 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
(fluticasone propionate + salmeterol xinafoate) 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
docetaxel 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
octreotide acetate SR 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
SUN-0597 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
brimonidine tartrate 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
hydrocodone bitartrate 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
minocycline hydrochloride 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
morphine sulfate 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
oxycodone hydrochloride 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Gene Therapy for Ocular Diseases 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Sun Pharma Advanced Research Company Ltd. - Pipeline Analysis 39
Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Target 39
Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Route of Administration 40
Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Molecule Type 41
Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Mechanism of Action 42
Sun Pharma Advanced Research Company Ltd. - Recent Pipeline Updates 44
Sun Pharma Advanced Research Company Ltd. - Dormant Projects 46
Sun Pharma Advanced Research Company Ltd. - Discontinued Pipeline Products 47
Discontinued Pipeline Product Profiles 47
baclofen ER 47
RBx-10558 47
SUN-0597 47
SUN-09 IR 48
SUN-09 Slow Release 48
SUN-1334H 48
SUN-44 48
SUNL-731 48
Sun Pharma Advanced Research Company Ltd. - Locations And Subsidiaries 49
Head Office 49
Appendix 50
Methodology 50
Coverage 50
Secondary Research 50
Primary Research 50
Expert Panel Validation 50
Contact Us 50
Disclaimer 51
List of Tables
Sun Pharma Advanced Research Company Ltd., Key Information 6
Sun Pharma Advanced Research Company Ltd., Key Facts 6
Sun Pharma Advanced Research Company Ltd. - Pipeline by Indication, 2016 8
Sun Pharma Advanced Research Company Ltd. - Pipeline by Stage of Development, 2016 10
Sun Pharma Advanced Research Company Ltd. - Monotherapy Products in Pipeline, 2016 11
Sun Pharma Advanced Research Company Ltd. - Combination Treatment Modalities in Pipeline, 2016 12
Sun Pharma Advanced Research Company Ltd. - Partnered Products in Pipeline, 2016 13
Sun Pharma Advanced Research Company Ltd. - Partnered Products/ Combination Treatment Modalities, 2016 14
Sun Pharma Advanced Research Company Ltd. - Pre-Registration, 2016 15
Sun Pharma Advanced Research Company Ltd. - Filing rejected/Withdrawn, 2016 16
Sun Pharma Advanced Research Company Ltd. - Phase III, 2016 17
Sun Pharma Advanced Research Company Ltd. - Phase II, 2016 18
Sun Pharma Advanced Research Company Ltd. - Phase I, 2016 19
Sun Pharma Advanced Research Company Ltd. - Preclinical, 2016 20
Sun Pharma Advanced Research Company Ltd. - Discovery, 2016 21
Sun Pharma Advanced Research Company Ltd. - Pipeline by Target, 2016 39
Sun Pharma Advanced Research Company Ltd. - Pipeline by Route of Administration, 2016 40
Sun Pharma Advanced Research Company Ltd. - Pipeline by Molecule Type, 2016 41
Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Mechanism of Action, 2016 42
Sun Pharma Advanced Research Company Ltd. - Recent Pipeline Updates, 2016 44
Sun Pharma Advanced Research Company Ltd. - Dormant Developmental Projects,2016 46
Sun Pharma Advanced Research Company Ltd. - Discontinued Pipeline Products, 2016 47
List of Figures
Sun Pharma Advanced Research Company Ltd. - Pipeline by Top 10 Indication, 2016 8
Sun Pharma Advanced Research Company Ltd. - Pipeline by Stage of Development, 2016 10
Sun Pharma Advanced Research Company Ltd. - Monotherapy Products in Pipeline, 2016 11
Sun Pharma Advanced Research Company Ltd. - Partnered Products in Pipeline, 2016 13
Sun Pharma Advanced Research Company Ltd. - Pipeline by Top 10 Target, 2016 39
Sun Pharma Advanced Research Company Ltd. - Pipeline by Route of Administration, 2016 40
Sun Pharma Advanced Research Company Ltd. - Pipeline by Molecule Type, 2016 41
Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016 42
